Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1957 studies found for:    alzheimer's
Show Display Options
Rank Status Study
21 Completed Clinical Trial of Donepezil Between the Patients With Alzheimer's Disease and Mixed Dementia
Conditions: Alzheimer's Disease;   Dementia
Intervention: Drug: donepezil
22 Recruiting Study of the Safety & Efficacy of Leukine® in the Treatment of Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Sagramostim;   Drug: Saline -- placebo comparator
23 Recruiting Study to Evaluate the Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease
Condition: Mild to Moderate Alzheimer's Disease
Intervention: Drug: Rivastigmine Patch
24 Completed
Has Results
A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease
Condition: Alzheimer´s Disease
Interventions: Biological: Immune Globulin Intravenous (Human), 10% (IGIV, 10%) 400 mg/kg;   Biological: Immune Globulin Intravenous (Human), 10% (IGIV, 10%) 200 mg/kg;   Biological: Placebo solution: Human Albumin 0.25% - 4 mL/kg;   Biological: Placebo solution: Human Albumin 0.25% - 2 mL/kg
25 Recruiting A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: CAD106 Immunotherapy;   Other: Placebo to CAD106;   Drug: CNP520;   Other: Placebo to CNP520
26 Recruiting The Safety and Efficacy of Long-term Treatment of PINS Stimulator System for Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Device: Deep Brain Stimulation (Beijing PINS Medical Co., Ltd)
27 Completed Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ST101;   Drug: Placebo
28 Terminated
Has Results
Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Memantine;   Drug: Placebo
29 Recruiting Study to Evaluate Coconut Oil for Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Coconut Oil Beverage;   Other: Placebo Beverage
30 Recruiting A Plan on Investigation and Collection of Aricept Safety Information With a Dose Increase on Alzheimer's Disease Patients
Condition: Alzheimer's Disease
Intervention: Drug: Aricept
31 Completed Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: ST101;   Drug: Placebo
32 Completed
Has Results
Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver Training
Condition: Alzheimer's Disease
Interventions: Behavioral: Individualized management of AD including caregiver training;   Drug: Memantine
33 Completed A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Dimebon;   Drug: Placebo
34 Unknown  Evaluation of 3APS in Patients With Mild to Moderate Alzheimer’s Disease
Condition: Alzheimer Disease
Intervention: Drug: 3APS
35 Completed Life From Vision in Alzheimer Disease
Conditions: Alzheimer Disease;   Cataract
Intervention: Behavioral: Questionaries
36 Unknown  Safety and Efficacy Study of Magnetic Fields to Treat Alzheimer's Disease
Condition: Alzheimer's Dementia
Intervention: Device: Resonator
37 Completed Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: PF-04360365 8.5 mg/kg;   Drug: Placebo
38 Completed Modulation of Abeta Levels by GSK933776 in Alzheimer's Disease Patient
Condition: Alzheimer's Disease
Intervention: Biological: GSK933776
39 Completed Double-blind, Placebo-controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Dimebon;   Drug: Placebo
40 Enrolling by invitation EEG/ERP Longitudinal Study in Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
Interventions: Procedure: ERP/EEG test;   Procedure: Psychometric testing

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.